by Kazeem Olalekan
Attention has just been drawn to the Drug Safety Update on Febuxostat (Adenuric) via the PJOnline website. In summary, there have been rare but serious reports of hypersensitivity reactions, including Stevens-Johnson syndrome and acute anaphylactic shock, with febuxostat (Adenuric). Febuxostat must be stopped immediately if hypersensitivity occurs, and must not be re-started in patients who have ever developed a hypersensitivity reaction to febuxostat.
The Safety Update provide the following advice to healthcare professionals:
….and I only dispensed the product to one of my patients last Saturday. I will now find that patient and impart this caution….without scaring them of course!